PMV Pharmaceuticals's total assets for Q1 2025 were $170.61M, a decrease of -10.81% from the previous quarter. PMVP total liabilities were $10.50M for the fiscal quarter, a -30.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.